Trial · NCT04375397
Results by group53
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 53
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Alive and Without Respiratory Failure Through Day 28 | Ibrutinib 420 mg + SOC | 86.4 | 80% Confidence Interval 74.4 to 93.2 | percentage of participants | |
| Percentage of Participants Alive and Without Respiratory Failure Through Day 28 | Placebo + SOC | 79.2 | 80% Confidence Interval 66.9 to 87.7 | percentage of participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Ibrutinib 420 mg + SOC | -4 points | 2 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Placebo + SOC | -4 points | 3 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Ibrutinib 420 mg + SOC | -3 points | 12 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Placebo + SOC | -3 points | 9 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Ibrutinib 420 mg + SOC | -2 points | 5 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Placebo + SOC | -2 points | 7 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Ibrutinib 420 mg + SOC | -1 point | 0 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Placebo + SOC | -1 point | 2 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Ibrutinib 420 mg + SOC | 0 points | 1 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Placebo + SOC | 0 points | 1 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Ibrutinib 420 mg + SOC | 1 point | 1 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Placebo + SOC | 1 point | 1 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Ibrutinib 420 mg + SOC | 3 points | 1 | Participants | |
| Change in the World Health Organization (WHO)-8 Ordinal Scale From Baseline at Study Day 14 | Placebo + SOC | 3 points | 1 | Participants | |
| Median Reduction in Days Spent on Supplemental Oxygen | Ibrutinib 420 mg + SOC | 5.0 | Full Range 1 to 28 | days | |
| Median Reduction in Days Spent on Supplemental Oxygen | Placebo + SOC | 6.5 | Full Range 1 to 21 | days | |
| All-Cause Mortality at Study Days 7, 14, 21, and 28 | Ibrutinib 420 mg + SOC | Day 7 | 0 | 80% Confidence Interval 0.0 to 6.9 | percentage of participants |
| All-Cause Mortality at Study Days 7, 14, 21, and 28 | Placebo + SOC | Day 7 | 0 | 80% Confidence Interval 0.0 to 6.4 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04375397/results